SGP

At a glance

SpyGlass Pharma, Inc. (SGP) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Irvine, United States and has 76 employees. The company is worth $802.75M. The share price is 26.0% below its 52-week high of $32.44. One of the 38 superinvestors we track held it at the end of Q2 2026: Israel Englander (Millennium Management), at $11.29M. No open-market insider trades in it were filed over the last 30 days.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$802.75M

P/E

—

Forward P/E

—

P/B

3.5x

Dividend yield

0.00%

Payout

—

EPS

-$2.51

ROE

—

Profit margin

0.00%

Revenue growth

—

Beta

—

52-week high

$32.44

52-week low

$17.06

History

Year by year, from the annual reports; dividends from the payments themselves.

Investors holding this

Major managers that reported this stock in their latest 13F.

• IE
  Israel EnglanderHeld

  Millennium Management · Q2 2026
  $11.29M

  507.26K shares · 0.0% of portfolio

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company